Perceptive Advisors - NEOS THERAPEUTICS INC ownership

NEOS THERAPEUTICS INC's ticker is NEOS and the CUSIP is 64052L106. A total of 52 filers reported holding NEOS THERAPEUTICS INC in Q4 2016. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
Perceptive Advisors ownership history of NEOS THERAPEUTICS INC
ValueSharesWeighting
Q4 2017$3,060,000
+50900.0%
300,000
+28309.1%
0.10%
Q4 2016$6,000
-99.7%
1,056
-99.7%
0.00%
-100.0%
Q3 2016$2,175,000
-52.8%
330,593
-47.3%
0.14%
-56.2%
Q2 2016$4,611,000
+327.3%
626,876
+526.9%
0.32%
+236.8%
Q1 2016$1,079,000
-47.2%
100,000
-29.9%
0.10%
-37.1%
Q4 2015$2,042,000
-86.9%
142,603
-80.8%
0.15%
-75.8%
Q3 2015$15,592,000742,1320.62%
Other shareholders
NEOS THERAPEUTICS INC shareholders Q4 2016
NameSharesValueWeighting ↓
Stonepine Capital Management, LLC 4,962,657$3,100,0002.37%
HUNTER ASSOCIATES INVESTMENT MANAGEMENT LLC 100,000$62,0000.02%
SlateStone Wealth, LLC 62,000$39,0000.01%
Allred Capital Management, LLC 24,995$15,0000.01%
Bridge Advisory, LLC 23,564$15,0000.01%
Livingston Group Asset Management CO (operating as Southport Capital Management) 24,000$15,0000.01%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 320,993$201,0000.00%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 229,500$143,0000.00%
Virtu Financial LLC 41,401$26,0000.00%
TSFG, LLC 200$1,0000.00%
View complete list of NEOS THERAPEUTICS INC shareholders